Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HZNP | AMGN | VRTX | BMY | GILD |
| Company | Horizon Therapeutics | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 116.34 | 320.58 | 480.00 | 55.50 | 89.80 |
| High | 116.38 | 320.58 | 480.00 | 55.50 | 89.80 |
| Low | 116.26 | 314.61 | 480.00 | 55.50 | 89.80 |
| Last | 116.30 | 316.91 | 480.00 | 55.50 | 89.80 |
| Change | +0.05 | -2.31 | +7.20 | +0.05 | -0.04 |
| % Change | +0.04% | -0.72% | +1.52% | +0.09% | -0.04% |
| Volume | 28,881,200 | 2,090,100 | 1,689 | 1,485 | 834 |
| 20-Day Average Volume | 3,994,490 | 1,721,105 | 986,874 | 8,250,944 | 4,958,867 |
| Previous Close | 116.25 | 319.22 | 472.80 | 55.45 | 89.84 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 115.61 | 319.64 | 477.92 | 53.21 | 87.50 |
| 20-Day Raw Stochastic | 95.09% | 33.87% | 55.53% | 85.69% | 86.10% |
| 20-Day Relative Strength | 80.29% | 45.54% | 52.91% | 62.82% | 68.67% |
| Weighted Alpha | +49.30 | +15.56 | +25.58 | +16.97 | +26.83 |
| Today's Opinion | 88% Buy | 8% Buy | 88% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 88% Buy | 8% Buy | 24% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 40% Buy | 24% Buy | 8% Sell | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.53% since 09/28/23 | -0.08% since 10/28/24 | +2.05% since 10/29/24 | +5.71% since 10/29/24 | +1.95% since 10/29/24 |
| Low | 115.66 on 09/29/23 | 310.63 on 10/30/24 | 463.14 on 11/01/24 | 52.29 on 10/30/24 | 87.48 on 10/30/24 |
| High | 116.38 on 10/05/23 | 323.40 on 10/31/24 | 480.00 on 11/05/24 | 56.20 on 10/31/24 | 90.71 on 11/04/24 |
| 1-Month | |||||
| %Chg | +0.68% since 09/05/23 | -0.86% since 10/04/24 | +5.42% since 10/04/24 | +2.85% since 10/04/24 | +6.16% since 10/04/24 |
| Low | 114.75 on 09/11/23 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 51.31 on 10/15/24 | 84.17 on 10/11/24 |
| High | 116.38 on 10/05/23 | 329.17 on 10/11/24 | 499.09 on 10/17/24 | 56.20 on 10/31/24 | 90.71 on 11/04/24 |
| 3-Month | |||||
| %Chg | +12.95% since 07/05/23 | -5.11% since 08/02/24 | +0.65% since 08/05/24 | +16.62% since 08/05/24 | +20.01% since 08/05/24 |
| Low | 98.80 on 08/03/23 | 306.59 on 08/07/24 | 447.70 on 10/07/24 | 46.22 on 08/08/24 | 72.43 on 08/12/24 |
| High | 116.38 on 10/05/23 | 339.17 on 09/23/24 | 500.25 on 08/30/24 | 56.20 on 10/31/24 | 90.71 on 11/04/24 |
| 6-Month | |||||
| %Chg | +7.70% since 04/05/23 | +1.81% since 05/03/24 | +19.68% since 05/03/24 | +26.17% since 05/03/24 | +38.62% since 05/03/24 |
| Low | 90.56 on 05/16/23 | 295.30 on 06/13/24 | 394.03 on 05/07/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 116.38 on 10/05/23 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 56.20 on 10/31/24 | 90.71 on 11/04/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 26,632,118 | 170,284,928 | 122,030,624 | 112,462,416 | 111,850,072 |
| Shares Outstanding, K | 228,995 | 537,329 | 258,102 | 2,028,177 | 1,244,992 |
| Annual Sales | 3,629,040,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | 521,480,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 944,960,000 | 8,503,000,000 | 2,645,600,000 | 11,892,000,000 | 6,954,000,000 |
| Last Quarter Net Income | 127,070,000 | 2,830,000,000 | -3,593,600,000 | 1,211,000,000 | 1,614,000,000 |
| 60-Month Beta | 1.03 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.20 on 08/08/23 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 11/01/23 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 25.89 | 16.61 | 0.00 | 46.43 | 19.04 |